UNSPSC 51371804: Piritramide

This classification denotes an opioid analgesic, narcotic, and isonipecotic acid with the molecular formula C27H34N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4RP92LYZ2F, chemically known as 2,2-diphenyl-4-(4-piperidino-4-carbamoylpiperidino)butyronitrile but generally known as piritramide, which bears US NIH Compound Identifier 9331. European Medicines Agency schedules Piritramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09920MIG.

UNSPSC 51371804 Piritramide is a Commodity code covering a specific pharmaceutical product, though the most recent state and local solicitation activity under this code reflects procurement of naloxone and drug deactivation systems rather than piritramide itself. State and local governments use this code category for acquisition of specialized pharmaceutical and medical supplies tied to public health and emergency response initiatives. The issuing bodies soliciting under this code include county health departments and public health agencies pursuing competitive bidding processes to meet community health and harm-reduction objectives.

Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid deadline was July 26, 2023. The contract carries a two-year initial term with one-year renewal option, includes probationary termination rights for the county, and requires vendors to meet E-Verify compliance, drug-free workplace certification, and specified insurance coverage including workers' compensation and commercial general liability. Potential FEMA funding introduces additional federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act. Recent activity under this code remains limited to the Florida opportunity; broader geographic spread or patterns of repeat issuing bodies are not evident in current state and local procurement data.